What Are the Challenges of Using Magnetic Nanoparticles in Cancer?
Despite their potential, several challenges need to be addressed:
Biocompatibility: Ensuring that MNPs are biocompatible and do not induce adverse immune responses is crucial. Targeting Accuracy: Achieving precise targeting to avoid off-target effects remains a significant challenge. Regulatory Hurdles: Extensive clinical trials and regulatory approvals are required for the safe use of MNPs in humans.
